United States · FDA National Drug Code directory
Acyclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8203_67f406ad-9398-4613-a77a-439966f1d0ae
- Product NDC
- 68788-8203
- Form
- TABLET
- Composition / generic term
- Acyclovir
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220526
- Source listing expiry
- 20271231
Source-listed ingredients
- ACYCLOVIR — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-8203-1) · 68788-8203-1
- 21 TABLET in 1 BOTTLE (68788-8203-2) · 68788-8203-2
- 30 TABLET in 1 BOTTLE (68788-8203-3) · 68788-8203-3
- 40 TABLET in 1 BOTTLE (68788-8203-4) · 68788-8203-4
- 50 TABLET in 1 BOTTLE (68788-8203-5) · 68788-8203-5
- 35 TABLET in 1 BOTTLE (68788-8203-8) · 68788-8203-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →